| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $5.78B | -4.1% |
| Cost of Revenue | $4.63B | -1.9% |
| Gross Profit | $1.15B | -11.9% |
| R&D Expense | $109.0M | +0.9% |
| SG&A Expense | $585.0M | -54.7% |
| Interest Expense | $264.0M | +26.9% |
| Pre-tax Income | $127.0M | +139.9% |
| Income Tax | $41.0M | +150.6% |
| Net Income | $86.0M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $713.0M | -40.7% |
| Accounts Receivable | $619.0M | +21.6% |
| Inventory | $1.47B | +8.9% |
| Current Assets | $3.03B | -21.1% |
| Total Assets | $7.51B | -8.9% |
| Current Liabilities | $1.80B | -27.5% |
| Long-term Debt | $4.05B | +1.7% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$633.0M | -213.8% |
| Capital Expenditures | $360.0M | -2.7% |
| Investing Cash Flow | -$353.0M | -54.1% |
| Financing Cash Flow | -$36.0M | -120.9% |
| Free Cash Flow | -$993.0M | -633.9% |
| +136.1% |
| EPS (Basic) | $0.58 | +136.3% |
| EPS (Diluted) | $0.57 | +135.6% |
| Total Liabilities |
| $6.91B |
| -8.0% |
| Stockholders' Equity | $604.0M | -18.0% |